Egg Enclosed In Shell Or A Part Thereof (e.g., Eggshell, Egg Yolk, Etc.) Patents (Class 424/581)
  • Patent number: 6506597
    Abstract: Improved artificial diets or growth media are described which are suitable for rearing large numbers of viable and biologically fit arthropods, including zoophagous arthropods and phytophagous arthropods, including facultatively zoophagous arthropods. In a first embodiment, the growth medium is composed of a mixture of cooked egg, liquid, and carbohydrate source. In a second embodiment, the growth medium is composed of a plant-based phytophage diet which includes cooked egg yolk or cooked whole egg. In a third embodiment, the growth medium is composed of a mixture of cooked egg, liquid, and carbohydrate source in admixture with a plant-based phytophage diet which includes cooked egg yolk or cooked whole egg. The growth media are devoid of meat products or insect components and are suitable for mass production of arthropods at a reasonable cost for use in biological control programs or other biologically based technologies.
    Type: Grant
    Filed: April 24, 2001
    Date of Patent: January 14, 2003
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventor: Allen C. Cohen
  • Publication number: 20030003117
    Abstract: The present invention provides a formulation comprising hydrolyzed whole egg, an emollient substance and a humectant substance; and provides a method of incorporating a hydrolyzed whole egg into a cosmetic, pharmaceutical and medicinal formulation wherein the hydrolyzed whole egg acts as a nutrient source and as a carrier of the active ingredients in the formulation to desired bodily targets.
    Type: Application
    Filed: January 8, 2002
    Publication date: January 2, 2003
    Inventors: Michael Marenick, Alyson Galderisi
  • Patent number: 6475504
    Abstract: What is disclosed is a method for the formation of unique poly(vinyl alcohol) hydrogels, articles that are made from such hydrogels, unique odor-providing pest repellent compositions and their uses to repel pests.
    Type: Grant
    Filed: October 25, 1995
    Date of Patent: November 5, 2002
    Inventor: Howard Franklin Stewart
  • Publication number: 20020136778
    Abstract: Improved feed compositions for lactating ruminants are provided that employ a high quality inedible egg product to increase the butterfat content and the milk protein content of the ruminant's milk. These improved compositions include one or more high quality inedible egg products in an amount from about 1% to 100% of the total weight of the composition. The balance of these improved compositions may consist of any ingredient(s) in any combination when such composition is capable of meeting or exceeding the nutritional requirements of the species to be fed. One aspect of the present invention provides a method for producing a high quality inedible egg product. In another aspect of the invention, there are provided feedstuff compositions for lactating ruminants that may be adapted to various stages of lactation.
    Type: Application
    Filed: January 10, 2001
    Publication date: September 26, 2002
    Inventors: Robert M. Claycamp, Robin L. Hayes
  • Publication number: 20020136727
    Abstract: A microbial adherence inhibitor in the form of fowl egg antibodies is disclosed, along with the method of making it and methods of using it. The inhibitor functions by substantially preventing the attachment or adherence of colony-forming immunogens in the rumen and intestinal tracts of host food animals. The inhibitor is made by inoculating female birds with the immunogen, harvesting the eggs which contain antibodies to the immunogen, harvesting the eggs which contain antibodies to the immunogen, drying the egg contents and adding to the feed or water for the host animals.
    Type: Application
    Filed: December 26, 2001
    Publication date: September 26, 2002
    Inventors: Peter Nash, John W. Rosevear, D. L. Robinson, Donald L. Robinson
  • Patent number: 6420337
    Abstract: Disclosed is an isolated Cytokine Activating Factor (CAF) protein, an isolated nucleic acid molecule encoding a CAF protein, an antibody that selectively binds to a CAF protein, a composition comprising a Cytokine Activating Factor (CAF), and a method for modulating the immune system using the composition. Also disclosed is a method for treating cancer using such a composition.
    Type: Grant
    Filed: July 20, 2000
    Date of Patent: July 16, 2002
    Assignee: Arkion Life Sciences LLC
    Inventors: Subramanian Iyer, Tay N. Nguyen, Dauh-Rurng Wu, Ruye Xing
  • Publication number: 20020090400
    Abstract: The present invention pertains to a method for the preparation of putamen ovi, putamen ovi having a defined grain size distribution, and to the use of putamen ovi for the treatment of calcium deficiency and other disease conditions.
    Type: Application
    Filed: December 21, 2001
    Publication date: July 11, 2002
    Inventor: Michel Ruepp
  • Patent number: 6410060
    Abstract: This invention relates to the method of non-invasively fortifying eggs with iodine as a dietary supplement without compromising the structural integrity of the egg. The eggs are placed in a solution comprising iodide or iodate salts of alkali or alkali earth metals at an effective concentration for a duration of between a few seconds to a few days. Iodine then passes through the egg shell to the interior of the egg until an adequate internal iodine concentration of iodide or iodate salts is produced.
    Type: Grant
    Filed: May 19, 1998
    Date of Patent: June 25, 2002
    Assignee: Biophile Corporation
    Inventors: Pichit Suvanprakorn, Lerson Tanasugarn, Anusig Limahksohn, Sangsom Sinawat, Prakrom Vuthipongse
  • Patent number: 6372240
    Abstract: A deer repellent formulation and method for warding off a deer from a shrub or plant. The formulation is an admixture of water, Rosemary oil emulsion, mint oil emulsion, a thickener, white distilled vinegar and dry eggs. The formulation can be applied to a support medium such as clay or a length of rope and then associated with the vegetation to be protected. The formulation can also be formed into a viscous composition and used in containers near the vegetation to be protected.
    Type: Grant
    Filed: September 25, 2000
    Date of Patent: April 16, 2002
    Inventor: James Messina
  • Patent number: 6372263
    Abstract: The invention relates to an active substance inhibiting tumorous proliferation in ectoderm derived tissues and to a composition containing such substance.
    Type: Grant
    Filed: September 23, 1999
    Date of Patent: April 16, 2002
    Inventor: Gyula Magvasi
  • Patent number: 6344217
    Abstract: The present invention pertains to a method for the preparation of putamen ovi, putamen ovi having a defined grain size distribution, and to the use of putamen ovi for the treatment of calcium deficiency and other disease conditions.
    Type: Grant
    Filed: April 24, 1998
    Date of Patent: February 5, 2002
    Assignee: AAR Pharma Adler Apotheke
    Inventor: Michel O. Ruepp
  • Publication number: 20010021393
    Abstract: The present invention provides specific antibodies obtained from eggs laid by hens which have been immunized against urease of Helicobacter pylori as an antigen, and specific antibodies obtained from eggs laid by hens which have been immunized against flagella of Helicobacter pylori as an antigen. These antibodies are useful for the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers caused by infection of Helicobacter pylori. At least one organism selected from lactic acid bacteria, Enterococcuses, yeasts, and Baillus can be used along with the antibodies.
    Type: Application
    Filed: April 8, 1998
    Publication date: September 13, 2001
    Inventors: YOSHIKATSU KODAMA, FAUSTINO C. ICATLO, NOBUTAKE KIMURA, MASATO ARIGA
  • Patent number: 6261597
    Abstract: A method of improving the periodontal condition of a person is disclosed. A suspension of small, unilamellar vesicles composed primarily of phospholipids, similar in nature to those of egg phosphatidylcholine, is administered parenterally to a person suffering from periodontal disease. In the method, liposomes are infused over an extended period of time of at least several weeks, until a desired improvement in gum condition is achieved.
    Type: Grant
    Filed: December 3, 1999
    Date of Patent: July 17, 2001
    Inventor: Seymour J. Kurtz
  • Patent number: 6245567
    Abstract: The present invention concerns products and methods particularly useful for activating and analyzing non-dividing cell nuclei. The featured products include activating egg extracts, cytostatic factor (CSF) extracts, kits containing these extracts, and a microchamber microscope slide useful in analyzing nucleus activation.
    Type: Grant
    Filed: March 30, 1998
    Date of Patent: June 12, 2001
    Assignee: Brandeis University
    Inventor: Lawrence J. Wangh
  • Patent number: 6217865
    Abstract: The invention relates to blending eggs from all egg lots produced over a predetermined time period of the egg laying cycle of immunized avians, to form an antibody-containing substance. The administration of an effective amount of such a blended antibody-containing substance to a subject increases the efficacy of the antibody in the subject over that of administering a substance containing the same amount of antibody obtained from eggs collected over less than the predetermined period of time.
    Type: Grant
    Filed: April 8, 1998
    Date of Patent: April 17, 2001
    Assignee: DCV, Inc.
    Inventor: Jeffrey G. Hunchar
  • Patent number: 6171858
    Abstract: A process is disclosed for determining the phototoxicity and/or photosensitivity of substances or substance mixtures, involving putting the chemical substance or substance mixture into contact with a non-human vertebrate embryo or tissues or tissue components of a vertebrate embryo, except for human skin cell cultures, whereby, following the contact, there is also a treatment with electromagnetic radiation ranging from 1 mm to 200 nm, followed by evaluation of the pathology of the embryo, tissue or cell; also disclosed is the use of a non-human vertebrate embryo or tissues or tissue components of such an embryo, except for human cell cultures, for purposes of determining the phototoxicity and/or photosensitivity of chemical substances/substance mixtures.
    Type: Grant
    Filed: March 11, 1999
    Date of Patent: January 9, 2001
    Inventors: Erhard Hölzle, Martin Rosenbruch, Gerd Plewig, Percy Lehmann, Norbert J. Neumann
  • Patent number: 6004586
    Abstract: A purified polypeptide which provides for initial binding of sperm to oocyte investments and has an active amino acid sequence of SEQ ID NO:12 (Cys-Gln-Ser-Leu-Gln-Glu-Tyr-Leu-Ala-Glu-Gln-Asn-Gln-Arg-Gln-Leu-Glu-Ser-A sn-Lys-Ile-Pro-Glu-Val-Asp-Leu-Ala-Arg-Val-Val-Ala-Pro-Phe-Met-Ser-Asn-Ile- Pro-Leu-Leu-Leu-Tyr-Pro-Gln-Asp-Arg-Pro-Arg-Ser-Gln-Pro-Gln-Pro-Lys-Ala-Asn -Glu-Asp-Val-Cys); or SEQ ID NO:13 (Cys-Glu-Ser-Leu-Gln-Lys-His-Leu-Ala-Glu-Leu-Asn-His-Gln-Lys-Gln-Leu-Glu-S er-Asn-Lys-Ile-Pro-Glu-Leu-Asp-Met-Thr-Glu-Val-Val-Ala-Pro-Phe-Met-Ala-Asn- Ile-Pro-Leu-Leu-Leu-Tyr-Pro-Gln-Asp-Gly-Pro-Arg-Ser-Lys-Pro-Gln-Pro-Lys-Asp -Asn-Gly-Asp-Val-Cys); or the shorter but biologically active SEQ ID NO:1 and SEQ ID NO:9 (Tyr-Pro-Gln-Asp-Arg-X-Arg-Ser-Gln-Pro-Gln-Pro-Lys-Ala-Asn, where X is Thr or Pro).
    Type: Grant
    Filed: February 20, 1998
    Date of Patent: December 21, 1999
    Assignee: The Penn State Research Foundation
    Inventors: Roy H. Hammerstedt, Palmer G. Cramer, Guy F. Barbato
  • Patent number: 5994322
    Abstract: Compositions for preventing or treating memory loss in the brain, comprising an effective amount of a mixture of lecithin and vitamin B.sub.12.
    Type: Grant
    Filed: April 16, 1996
    Date of Patent: November 30, 1999
    Assignee: Kewpie Kabusiki Kaisya
    Inventors: Yasunobu Masuda, Toyohiko Kokubu, Norimitsu Yamagata
  • Patent number: 5976519
    Abstract: A hair care product contains a yolk antibody (a yolk-derived, anti-hair antibody) which has been obtained from an egg of a domestic fowl immunized using, as an antigen, whole human hair, e.g., normal human hair or human hair damaged by permanent waving, dyeing or bleaching, hair particles obtained by grinding constituent tissues of human hair, the keratin protein extracted from the human hair, or a hydrolysate of the keratin protein.
    Type: Grant
    Filed: November 12, 1992
    Date of Patent: November 2, 1999
    Assignees: Kao Corporation, Taiyo Kagaku Co., Ltd.
    Inventors: Hiroshi Nojiri, Sachio Naito, Hidehisa Takahashi, Masaru Fujiki, Mujo Kim
  • Patent number: 5932250
    Abstract: The present invention is directed to the treatment of vascular disorders particularly arteriosclerosis and atherosclerosis in warm-blooded animals. The invention encompasses the ingestion, by warm-blooded animals, of eggs or egg fractions derived from female avians that have been hyperimmunized with specific bacterial antigens or groups of bacterial antigens. The invention is directed to methods of controlling cholesterol levels, lipid deposits, and the development of atheromatous lesions in warm-blooded animals by the ingestion of eggs or fractions thereof produced in female avians hyperimmunized with specific bacterial antigens. The invention is also directed to methods of producing the eggs and to vaccines for hyperimmunization of the female avians.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 3, 1999
    Assignee: DCV, Inc.
    Inventors: Ralph J. Stolle, Lee R. Beck
  • Patent number: 5883231
    Abstract: There is provided a bodily fluid simulant made from red blood cells in an amount between about 10 and about 60 weight percent, egg white in an amount between 20 and 50 weight percent, and plasma.
    Type: Grant
    Filed: August 21, 1997
    Date of Patent: March 16, 1999
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Amy Michele Achter, Crystal Sutphin Leach, Jack Nelson Lindon, Heather Anne Sorebo, Mary Garvie Weber
  • Patent number: 5877223
    Abstract: Certain volatile compounds naturally present in herring gull eggs are effective for repelling animals and birds, particularly canids, from the locus to which such compounds are applied. More particularly, the volatile compounds which are effective animal repellents include compounds exhibiting mint-like odors such as the compounds pulegone and piperitone. The invention relates to methods of using these compounds to repel animals, and to repellent compositions comprising effective repellent amounts of such compounds.
    Type: Grant
    Filed: March 8, 1990
    Date of Patent: March 2, 1999
    Assignee: Monell Chemical Senses Center
    Inventors: James Russell Mason, Richard Albert Dolbeer, George Preti
  • Patent number: 5853765
    Abstract: The present invention is directed to the treatment of vascular disorders particularly arteriosclerosis and atherosclerosis in warm-blooded animals. The invention encompasses the ingestion, by warm-blooded animals, of eggs or egg fractions derived from female avians that have been hyperimmunized with specific bacterial antigens or groups of bacterial antigens. The invention is directed to methods of controlling cholesterol levels, lipid deposits, and the development of atheromatous lesions in warm-blooded animals by the ingestion of eggs or fractions thereof produced in female avians hyperimmunized with specific bacterial antigens. The invention is also directed to methods of producing the eggs and to vaccines for hyperimmunization of the female avians.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 29, 1998
    Assignee: DCV, Inc.
    Inventors: Ralph J. Stolle, Lee R. Beck
  • Patent number: 5807551
    Abstract: The invention provides methods for inducing long-term passive immunity in birds, through administration of superconcentrated antibodies to hatching eggs or to post-hatch birds. The superconcentrated antibodies may originate from any source, including avian or mammalian species, and are specific for one or more disease agents against which passive protection is desired.
    Type: Grant
    Filed: August 21, 1996
    Date of Patent: September 15, 1998
    Assignee: Iowa State University Research Foundation, Inc.
    Inventor: Donald L. Reynolds
  • Patent number: 5763206
    Abstract: A method for testing the potential fertility of spermatozoa in a sample by contacting an aliquot of the sperm sample onto a protein extracted from native vitelline membranes removed from chicken or turkey eggs to enable quantification of the number of sperm which bind to the protein. Typically, the vitelline membrane protein is coated onto a solid substrate and the protein extract is first prepared by dissecting vitelline membranes (lamina perivitelline plus lamina extravitellina) from either a group of chicken eggs or a group of turkey eggs, rinsing the membranes free of albumin and yolk, and subdividing the membranes into small particles. The resulting protein is heat solubilized, purified with centrifugation and concentrated to yield the protein extract in solution. The extracted protein then is used as a protein substrate for spermatozoa binding, with sequential contacting of the protein extract with the spermatozoa and measuring the amount of sperm-egg binding that takes place.
    Type: Grant
    Filed: February 13, 1996
    Date of Patent: June 9, 1998
    Assignee: The Penn State Research Foundation
    Inventors: Roy H. Hammerstedt, Guy F. Barbato, Palmer G. Cramer
  • Patent number: 5753268
    Abstract: Anti-cholesterolemic eggs are disclosed, said eggs being obtained from animals hyperimmunized against at least one anti-cholesterolemic antigen. A vaccine producing said anti-cholesterblemic egg is disclosed, said vaccine comprising at least one anti-cholesterolemic antigen. Further, a dietary supplement for humans and other animals which does not elevate serum lipid, concentrations is disclosed, said supplement comprising the anti-cholesterolemic eggs or fractions thereof. A method for treating vascular disorders in humans and other animals is also disclosed which comprises administering to said subjects said anti-cholesterolemic eggs for a time and in amounts sufficient to produce anti-arteriosclerotic effects, anti-aging vascular effects, and/or serum lipid-lowering effects.
    Type: Grant
    Filed: February 15, 1991
    Date of Patent: May 19, 1998
    Assignee: DCV Biologics, L.P.
    Inventors: Ralph J. Stolle, Lee R. Beck
  • Patent number: 5676975
    Abstract: A method of producing a burn symptom relief composition and the burn relief composition is provided which includes the use of blending natural ingredients each to the other to produce the composition for relief of burn symptoms. The method of producing the burn relief composition includes initially separating eggs into egg yolks and egg albumen. The egg yolks are then incorporated into a mixed glyceride composition to form a first intermediate composition which is emulsified by the addition of an aqueous solution of calcium hydroxide. The egg albumen is then mixed with the first intermediate composition to form a second intermediate composition which is further emulsified by the addition of still further additions of aqueous solutions of a calcium hydrate composition which is then stored and applicable for topical application to a mammalian body to relieve the symptoms of pain due to burn conditions.
    Type: Grant
    Filed: June 29, 1995
    Date of Patent: October 14, 1997
    Inventors: Alexander C. Dezes, George A. Dezes
  • Patent number: 5670175
    Abstract: An ultrapure egg oil is prepared starting from dried and powdered avian or reptilian egg yolk by means of extraction with the aid of fat solvents, followed by two-step ageing, first at ambient temperature and then at a lowered temperature, separating off and centrifuging off the less viscous phase formed and again separating off the less viscous component. This component is, if appropriate repeatedly, mixed with demineralized water and heated, and, after cooling, the less viscous phase is separated off and again centrifuged, the less viscous component is again separated off and held at a lower temperature, the phases are again separated, and the less viscous component which has been separated off is recentrifuged.This again results in phase separation, the less viscous component which has been separated off being the end product which is a yellow to reddish, fluid oil which can be stored without preservatives.
    Type: Grant
    Filed: September 27, 1995
    Date of Patent: September 23, 1997
    Inventor: Werner C. Nawrocki
  • Patent number: 5460832
    Abstract: The invention is directed to a skin cosmetic comprising an egg white enzyme hydrolysate and/or a fractional component thereof which possesses hyaluronic acid synthesis promoting activity.
    Type: Grant
    Filed: January 29, 1993
    Date of Patent: October 24, 1995
    Assignee: Taiyo Kagaku Co., Ltd.
    Inventors: Hiroaki Yamaguchi, Akio Kawasaki, Masatsugu Yamashita
  • Patent number: 5437291
    Abstract: Direct injection of sphincteric botulinum toxin is disclosed as an effective, safe and simple method of treatment for disorders of gastrointestinal muscle or smooth muscles elsewhere in the body, with results that appear to be sustained for several months. Muscle disorders which are suitable for such treatment include achalasia, isolated disorders of the lower esophageal sphincter, gastroparesis, hypertrophic pyloric stenosis, sphincter of Oddi dysfunction, short-segment Hirschsprung's, anal fissure, hemorrhoids, proctalgia fugax, irritable bowel syndrome, disorders of the upper esophageal sphincter, vasospastic disorders, and disorders of uterine and bladder spasm. Devices suitable for delivering this therapy are also disclosed.
    Type: Grant
    Filed: August 26, 1993
    Date of Patent: August 1, 1995
    Inventors: Pankai J. Pasricha, Anthony N. Kalloo
  • Patent number: 5415879
    Abstract: Chickens are fed a composition including fish oil over a period of time. Modified eggs laid by such chickens contain substantial quantities of omega-3 polyunsaturated fatty acids. The modified eggs are fed to humans with the result that serum cholesterol, serum triglycerides and blood pressure are reduced as compared to humans eating a like number of regular eggs with a subsequent decrease in heart disease.
    Type: Grant
    Filed: August 29, 1994
    Date of Patent: May 16, 1995
    Inventor: Suk Y. Oh
  • Patent number: 5415875
    Abstract: An anti-peroxide external preparation for skin comprising: decomposition product of shell membrane: and tocopherol and/or derivatives thereof. It is possible to suppress formation of peroxide and remove it.
    Type: Grant
    Filed: October 22, 1993
    Date of Patent: May 16, 1995
    Assignee: Shiseido Co., Ltd.
    Inventors: Hiroyuki Kakoki, Yoshiyuki Kono, Shinichiro Funatsu, Masaaki Komatsu
  • Patent number: 5368866
    Abstract: A deer repellent composition for the protection of vegetation includes an active ingredient comprising egg and a red hot sauce, composed of pepper, vinegar, garlic, salt and water; a carrier; and a diluent. The vegetation is protected by applying an effective amount of the composition thereto, preferably by spraying. The composition may include the aforementioned ingredients in the following percentages: about 3-7 percent eggs; about 6-19 percent red hot sauce; about 3-7 percent carrier; and about 68-91 percent diluent, the total composition equaling 100 percent by weight. A process for preparing the mixture is also enclosed.
    Type: Grant
    Filed: October 25, 1993
    Date of Patent: November 29, 1994
    Inventor: Athena P. Loucas
  • Patent number: 5348866
    Abstract: This invention relates to a DNA sequence comprising at least part of a porcine zona pellucida PZP-4.alpha. or -4.beta. gene coding for an amino acid sequence represented by SEQ ID NO: 1 or SEQ ID NO: 2, respectively, in SEQUENCE LISTING.This invention also relates to an expression system and to expression of said DNA.In addition, this invention relates to an immunogenic recombinant polypeptide or peptide which comprises at least part of said amino acid sequence and which is obtained by expressing said DNA, and to a contraceptive vaccine for use in human or other animals which comprises said polypeptide or peptide as an active ingredient.
    Type: Grant
    Filed: March 20, 1992
    Date of Patent: September 20, 1994
    Assignees: Shinzo Isojima, Tonen Corporation
    Inventors: Shinzo Isojima, Akiko Akatani, Yuichi Okazaki, Masanobu Sugimoto
  • Patent number: 5223295
    Abstract: The present invention relates to a novel process for the elimination of steroid compounds contained in a substance of biological origin by complexing the steroidal compounds by means of a cyclodextrin, in an aqueous medium, under agitation at a temperature between 20.degree. and 80.degree. C. and then separating the complexes so formed.
    Type: Grant
    Filed: May 22, 1991
    Date of Patent: June 29, 1993
    Assignee: Asterol International
    Inventors: Jean-Pierre Maffrand, Jean Courregelongue
  • Patent number: 5045323
    Abstract: Eggshells are utilized after preliminary treatment for medical purposes for treating certain diseases and to compensate for deficiencies of mineral in living tissues, particularly in bone tissues in a form which is acceptable by the body.
    Type: Grant
    Filed: June 26, 1989
    Date of Patent: September 3, 1991
    Assignee: Zapadoslovanske hydinaarske zavody statny podnik
    Inventor: Karol Michalek
  • Patent number: 4965070
    Abstract: A deer repellent formulation for warding off a deer from a plant is provided. The deer repellent formulation includes, a volume of water; 12 fluid ounces of thiram in a water solution of 42% by volume of thiram, per gallon of the water; 2 whole chicken eggs per gallon of water; 2 ounces by volume of liquid hot sauce per gallon of water; green color dye in a sufficient quantity per gallon of the water to provide a plant-like green color of the formulation; and a liquid adhesive in sufficient quantity per gallon of the water to provide a desired stickiness on plants of the formulation.
    Type: Grant
    Filed: September 14, 1989
    Date of Patent: October 23, 1990
    Inventor: James J. Messina
  • Patent number: 4946678
    Abstract: A process and nourishing agent for treating and nourishing the scalp and hair to promote conditions for the natural growth of hair on a human head for the reversal of male pattern baldness in individual cases. The process includes the steps of cleansing the scalp and hair, opening the pores and follicles in the scalp and softening and removing clogging deposits from the pores and hair follicles, and then applying to the scalp a nourishing agent comprising a mixture of chalaza extracted from chicken eggs, unflavored powdered gelatin, and aqueous saline solution. In the preferred form of the invention, the pores of the scalp and hair follicles are opened and sanitized by repeated applications of a benzoic acid mixture and heat, and the clogging deposits and foreign matter are softened and separated by the application of a carbamide peroxide solution and heat.
    Type: Grant
    Filed: May 3, 1989
    Date of Patent: August 7, 1990
    Inventors: Thomas L. Dodd, David A. O'Steen